Coleman Mark 4
4 · Axsome Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-03$9.00/sh+9,127$82,143→ 57,137 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-01-03−9,127→ 0 totalExercise: $9.00From: 2016-11-19Exp: 2025-11-19→ Common Stock (9,127 underlying)
Holdings
- 403,856(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Represents the exercise of stock options prior to expiration for cash and hold of underlying shares.
- [F2]Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.